Your browser doesn't support javascript.
loading
Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.
Dhindsa, Ryan S; Mattsson, Johan; Nag, Abhishek; Wang, Quanli; Wain, Louise V; Allen, Richard; Wigmore, Eleanor M; Ibanez, Kristina; Vitsios, Dimitrios; Deevi, Sri V V; Wasilewski, Sebastian; Karlsson, Maria; Lassi, Glenda; Olsson, Henric; Muthas, Daniel; Monkley, Susan; Mackay, Alex; Murray, Lynne; Young, Simon; Haefliger, Carolina; Maher, Toby M; Belvisi, Maria G; Jenkins, Gisli; Molyneaux, Philip L; Platt, Adam; Petrovski, Slavé.
Afiliación
  • Dhindsa RS; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Mattsson J; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Nag A; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Wang Q; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Wain LV; Genetic Epidemiology Group, Department of Health Sciences George Davies Centre, University of Leicester, Leicester, UK.
  • Allen R; National Institute for Health Research, Leicester Respiratory Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
  • Wigmore EM; Genetic Epidemiology Group, Department of Health Sciences George Davies Centre, University of Leicester, Leicester, UK.
  • Ibanez K; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Vitsios D; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Deevi SVV; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Wasilewski S; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Karlsson M; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Lassi G; Lung Regeneration, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Olsson H; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Muthas D; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Monkley S; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Mackay A; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Murray L; Translational Science & Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Young S; Lung Regeneration, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Haefliger C; Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Belvisi MG; Royal Brompton Hospital, London, UK.
  • Jenkins G; Hastings Centre for Pulmonary Research and Division of Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Molyneaux PL; National Heart and Lung Institute, Imperial College, London, UK.
  • Platt A; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Petrovski S; Respiratory Pharmacology Group, London, UK.
Commun Biol ; 4(1): 392, 2021 03 23.
Article en En | MEDLINE | ID: mdl-33758299
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas de Ciclo Celular / Mutación Missense / Fibrosis Pulmonar Idiopática Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Commun Biol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas de Ciclo Celular / Mutación Missense / Fibrosis Pulmonar Idiopática Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Commun Biol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido